Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
about
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ TransplantationAdenosine receptors as therapeutic targetsA2A receptors in inflammation and injury: lessons learned from transgenic animalsAdenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemiaBeneficial and detrimental role of adenosine signaling in diseases and therapyAttenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats.Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient miceRole of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injuryAdenosine receptors as drug targets--what are the challenges?NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion InjuryThe immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Immunological alterations mediated by adenosine during host-microbial interactionsLinks between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humansTargeting of adenosine receptors in ischemia-reperfusion injury.Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cellsImmune mechanisms and novel pharmacological therapies of acute kidney injury.The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashionResolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationAdenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusionC-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury.Adenosine signaling during acute and chronic disease statesPreventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity.Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusionAdenosine receptors and renal ischaemia reperfusion injury.Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemiaCholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouseTargeting iNKT cells for the treatment of sickle cell disease.A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitisEffects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activatedIn vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.Dual roles of the adenosine A2a receptor in autoimmune neuroinflammationNeoceptors: reengineering GPCRs to recognize tailored ligandsAcute kidney injury after hepatic ischemia and reperfusion injury in mice.Molecular mediators of liver ischemia and reperfusion injury: a brief reviewIn vitro induction of T cells that are resistant to A2 adenosine receptor-mediated immunosuppression.Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor
P2860
Q21131166-551AD3F8-7370-4F09-8AE8-29D9124835B5Q24632095-2FE2B7EF-DAB4-4C50-B17A-5967E74E1DFAQ24652486-BC7E7B30-66BA-40C3-B16C-4371B04CC1DDQ26851322-C3AEF91E-CF38-4050-9F02-4E454583ECF8Q28080872-A4730002-48E9-421D-AC76-DED7F103537DQ28195202-8B09DFC8-8B6E-4B45-AB77-3D2B9B0ADA88Q28512453-BF94429B-9D4C-4646-ABE8-56230051654AQ28585044-384C0D64-01BB-4A7E-8F43-238708725947Q29346491-97771B1A-4A8B-484D-9F9C-1AF9DBC28DDDQ30277768-B0E36420-1957-44D4-B224-ADB2BEB4E27AQ30409961-5F390078-9C3C-45C7-9701-BEEEC3147228Q30426800-25EC9E64-8B3C-44B9-9E33-6A02BB34D06FQ30428503-EB29A986-7883-43A9-8332-596D394CCFC7Q30429069-108FCB4B-DA64-4587-943D-638F5A42FC9CQ30429393-890EF073-B01A-4BD3-B739-D52D04B4B91AQ30434114-1BB390C2-0D73-4FDF-BCE1-D2A08BB02771Q30434767-373F5A95-C51F-404A-8E36-892FCB5CF633Q30436868-C892DFD1-D82D-4067-A94A-7ABBDA74FDF3Q30437086-5F7255CF-528E-4EC8-AC3E-654759032DDFQ30437433-644053EA-CF09-4AA4-A086-48CDC08534E4Q30439172-60DE06A5-4EDE-4F9C-9210-BD766935F65AQ30442067-EB600546-62CA-42F4-884D-C04110FE618EQ33635113-2275130C-D653-4F94-A5F8-4252EB75CE92Q33808058-43460EC4-753C-4B14-BD1A-649D43E11E2BQ34035228-BD35262E-9E64-491F-80F8-60F5DD7D75D3Q34182797-876E9968-9D0F-46CC-AFC3-7C1A41E30D46Q34402761-75B0F871-53F2-48E8-BB2F-6F04BD3CA0A5Q34735024-7C7B4CF9-CE80-471E-970A-A34714CA2DD3Q35574518-F6BF6DF4-0855-4CF5-B3BA-A6CB78BE3FD8Q35761225-8A7465EC-39C9-42D1-8478-89624D0E9813Q35893688-56EFA249-17D3-46D9-8441-CA65BF0BAA2BQ35981065-292F548F-4B80-4363-A467-56FD4F33946CQ36052531-64CBF4EC-5A52-48C1-B73A-B098273B5A64Q36377291-7235E33E-401A-4A75-9F5C-C4B900051287Q36622141-1346B794-745F-49CE-8557-45FA2382BEE2Q36728991-35FA72D5-6277-4A9B-A16E-D869CFAA1726Q37076990-512BEF90-AFCF-4E19-8F56-F9B5B49FDC07Q37091752-4F3623AF-F47B-4600-AE4E-28A26039487CQ37231003-68B99FBF-F4A7-4DE2-8008-9926EAD193FBQ37297950-731A1C11-5F47-4963-9BA4-328347AF4269
P2860
Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Protection from ischemic liver ...... bition of chemokine induction.
@ast
Protection from ischemic liver ...... bition of chemokine induction.
@en
type
label
Protection from ischemic liver ...... bition of chemokine induction.
@ast
Protection from ischemic liver ...... bition of chemokine induction.
@en
prefLabel
Protection from ischemic liver ...... bition of chemokine induction.
@ast
Protection from ischemic liver ...... bition of chemokine induction.
@en
P2093
P356
P1476
Protection from ischemic liver ...... bition of chemokine induction.
@en
P2093
Joel Linden
Liping Huang
Marcia J McDuffie
Melissa A Marshall
Yuan-Ji Day
P304
P356
10.1152/AJPGI.00348.2003
P577
2004-02-01T00:00:00Z